patients	outcome	residual_tumor	Response	patients_name	Mandard	MFP_T1	MFP_T3	MFP_N	Group	
ESCC-P13	CR	0	Well responders	LJZ	TRG1	IE	IE/F	IE	T high	ESCC-P13
ESCC-P16	CR	0	Well responders	CJF	TRG1	IE	D	IE	T high	ESCC-P16
ESCC-P14	PR	2	Well responders	ZAL	TRG2	NA	IE	IE	T low	ESCC-P14
ESCC-P06	PR	2.9	Well responders	YSN	TRG2	IE	IE	D	T high	ESCC-P06
ESCC-P15	PR	5	Well responders	WWJ	TRG2	NA	NA	F	T low	#N/A
ESCC-P08	PR	7	Well responders	SLS	TRG2	IE	IE	D	T high	ESCC-P08
ESCC-P19	PR	13.3	Well responders	YUWM	TRG3	NA	IE	D	T low	ESCC-P19
ESCC-P09	PR	20	Well responders	WGF	TRG3	IE	IE	D	T high	ESCC-P09
ESCC-P05	PR	23.7	Well responders	FDY	TRG3	D	D	D	T low	ESCC-P05
ESCC-P01	PR	23.9	Well responders	SKA	TRG3	D	F	D	T low	ESCC-P01
ESCC-P02	PR	32.5	Well responders	YWM	TRG3	D	NA	D	T low	#N/A
ESCC-P25	SD	45	Poor responders	YHS	TRG3	NA	D	IE	T low	ESCC-P25
ESCC-P23	SD	52	Poor responders	WGS	TRG4	NA	IE	IE	T low	ESCC-P23
ESCC-P11	SD	53.3	Poor responders	ZHS	TRG4	IE	D	NA	T high	ESCC-P11
ESCC-P10	SD	57	Poor responders	XAH	TRG4	F	D	D	T low	ESCC-P10
ESCC-P12	SD	72.5	Poor responders	CCX	TRG4	IE/F	IE	IE	T low	ESCC-P12
ESCC-P07	SD	74.3	Poor responders	FDH	TRG4	D	D	IE	T low	ESCC-P07
ESCC-P04	SD	77.2	Poor responders	QHJ	TRG4	F	D	D	T low	ESCC-P04
ESCC-P21	SD	78.9	Poor responders	QHR	TRG4	F	IE/F	F	T low	ESCC-P21
ESCC-P22	SD	79.1	Poor responders	ZFM	TRG4	D	F	F	T high	ESCC-P22
ESCC-P03	SD	81.4	Poor responders	LNF	TRG4	D	F	IE	T low	ESCC-P03
ESCC-P17	SD	90	Poor responders	YHZ	TRG4	D	F	F	T low	ESCC-P17
ESCC-P24	SD	90	Poor responders	ZGQ	TRG4	NA	NA	NA	T low	#N/A
ESCC-P18	SD	90	Poor responders	ZY 	TRG4	NA	F	IE/F	T low	ESCC-P18
ESCC-P20	SD	90	Poor responders	ZGD	TRG4	F	F	F	T low	ESCC-P20